Skip to main content

Table 5 Comparison of metabolic indexes between the two groups

From: A nonrandomized controlled trial of individualized exercise prescription combined with remote exercise management in patients who are overweight or obese

  Experimental group (n = 55) Control group (n = 34) For delta indicators
Before intervention t−1 After intervention t0 Delta changes Before intervention t−1 After intervention t0 Delta changes t P
UA (μmol/L) 361.96 ± 96.55 357.56 ± 103.13 −9.75 ± 19.68 322.12 ± 90.45 307.96 ± 91.46 −1.31 ± 12.37 2.239 0.028
TC (mmol/L) 4.52 ± 0.71 4.40 ± 0.72 −0.11 ± 0.40 4.76 ± 0.81 4.95 ± 0.92 −0.11 ± 0.59 2.953 0.004
TG (mmol/L) 1.37 ± 0.65 1.31 ± 0.67 −0.07 ± 0.64 1.57 ± 1.42 1.47 ± 1.15 −0.11 ± 0.59 −0.319 0.750
LDL-C (mmol/L) 1.20 ± 0.19 1.23 ± 0.21 0.02 ± 0.13 1.29 ± 0.21 1.32 ± 0.24 0.04 ± 0.23 0.308 0.705
HDL-C (mmol/L) 2.77 ± 0.67 2.79 ± 0.68 0.03 ± 0.39 2.87 ± 0.66 3.01 ± 0.72 0.14 ± 0.40 1.286 0.202
HbA1c (%) 5.60 ± 0.45 5.63 ± 0.45 0.03 ± 0.37 5.58 ± 0.38 5.49 ± 0.36 −0.09 ± 0.26 −1.701 0.092
FBG (mmol/L) 5.21 ± 0.62 4.92 ± 0.5 −0.28 ± 0.52 5.07 ± 0.47 4.94 ± 0.74 −0.13 ± 0.69 1.229 0.222
FI (μU/mL) 11.16 ± 5.34 8.80 ± 5.60 −2.36 ± 5.20 11.45 ± 5.52 12.67 ± 7.59 1.22 ± 7.34 2.688 0.009
HOMA-IR 2.59 ± 1.40 1.97 ± 1.33 −0.62 ± 1.25 2.58 ± 1.25 2.72 ± 1.61 0.14 ± 1.83 2.327 0.022
  1. UA uric acid, TC total cholesterol, TG triglycerides, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, HbA1c hemoglobin A1c, FBG fasting blood glucose, FI fasting insulin, HOMA-IR homeostatic model assessment of insulin resistance